Drugs and Group Psychotherapy in Neurotic Depression
Abstract
Chronically depressed neurotic women outpatients were randomly assigned, after a two-week placebo washout period, to receive one of three medications (imipramine, diazepam, or placebo) and to either weekly group psychotherapy or biweekly brief supportive sessions at one of two clinics. Analyses of covariance for the first 16 weeks of active treatment (N = 146) indicated a marked therapeutic advantage for imipramine on most of the outcome measures. No advantage for group therapy was detected on these measures. Patients who showed improvement were continued in further controlled drug treatment for up to a total of 71 weeks; preliminary analyses of this phase showed some continuing advantage for treatment with imipramine.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
